126 related articles for article (PubMed ID: 35253360)
1. NUP214-ABL1 fusion in childhood T-ALL.
Veltri G; Sandei M; Silvestri D; Bresolin S; Pession A; Santoro N; Ziino O; Veltroni M; Rizzari C; Biffi A; Valsecchi MG; Conter V; Buldini B; Accordi B; Serafin V
Pediatr Blood Cancer; 2022 Sep; 69(9):e29643. PubMed ID: 35253360
[No Abstract] [Full Text] [Related]
2. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic
Stukaite-Ruibiene E; Norvilas R; Dirse V; Stankeviciene S; Vaitkeviciene GE
Pathol Oncol Res; 2022; 28():1610570. PubMed ID: 36172171
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.
Simioni C; Ultimo S; Martelli AM; Zauli G; Milani D; McCubrey JA; Capitani S; Neri LM
Oncotarget; 2016 Nov; 7(48):79842-79853. PubMed ID: 27821800
[TBL] [Abstract][Full Text] [Related]
4. NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
Burmeister T; Gökbuget N; Reinhardt R; Rieder H; Hoelzer D; Schwartz S
Blood; 2006 Nov; 108(10):3556-9. PubMed ID: 16873673
[TBL] [Abstract][Full Text] [Related]
5. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
[TBL] [Abstract][Full Text] [Related]
6. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
[TBL] [Abstract][Full Text] [Related]
7. NUP214::ABL1: A Ph-like fusion found in a pediatric acute myeloid leukemia patient with normal karyotype.
de Oliveira Mota F; Gamba FT; de Carvalho Pires MG; de Toledo SRC; Gouveia JT; Oliveira ID; da Silva Santos N; Delbuono E; Rhein BN; da Costa Guimarães RF; de Sousa AVL
Pediatr Blood Cancer; 2023 May; 70(5):e30203. PubMed ID: 36633225
[No Abstract] [Full Text] [Related]
8. Detection of a cryptic
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
De Keersmaecker K; Versele M; Cools J; Superti-Furga G; Hantschel O
Leukemia; 2008 Dec; 22(12):2208-16. PubMed ID: 18784740
[TBL] [Abstract][Full Text] [Related]
10. SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia.
Gorello P; La Starza R; Di Giacomo D; Messina M; Puzzolo MC; Crescenzi B; Santoro A; Chiaretti S; Mecucci C
Haematologica; 2010 Dec; 95(12):2161-3. PubMed ID: 20851865
[No Abstract] [Full Text] [Related]
11.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract][Full Text] [Related]
12. ABL1 fusions in T-cell acute lymphoblastic leukemia.
De Keersmaecker K
Verh K Acad Geneeskd Belg; 2008; 70(4):245-55. PubMed ID: 19166098
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia.
Cools J
Verh K Acad Geneeskd Belg; 2010; 72(1-2):55-70. PubMed ID: 20726440
[TBL] [Abstract][Full Text] [Related]
14. [Expression of SET-NUP214 fusion gene in patients with T-cell acute lymphoblastic leukemia and its clinical significance].
Dai HP; Wang Q; Wu LL; Ping NN; Wu CX; Xie JD; Pan JL; Xue YQ; Wu DP; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1047-51. PubMed ID: 23114116
[TBL] [Abstract][Full Text] [Related]
15. The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.
Wang J; Zhan QR; Lu XX; Zhang LJ; Wang XX; Zhang HY
Medicine (Baltimore); 2022 Jul; 101(30):e29294. PubMed ID: 35905214
[TBL] [Abstract][Full Text] [Related]
16. T-cell acute lymphoblastic leukemia associated with complex karyotype and SET-NUP214 rearrangement: a case study and review of the literature.
Lee SG; Park TS; Cho SY; Lim G; Park GJ; Oh SH; Cho EH; Chong SY; Huh JY
Ann Clin Lab Sci; 2011; 41(3):267-72. PubMed ID: 22075511
[TBL] [Abstract][Full Text] [Related]
17. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
[No Abstract] [Full Text] [Related]
18. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
19. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.
Clarke S; O'Reilly J; Romeo G; Cooney J
Leuk Res; 2011 Jul; 35(7):e131-3. PubMed ID: 21489623
[No Abstract] [Full Text] [Related]
20. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]